RX Pad Blog

Clinical Decision Support System Alerts

A blue and green circle with a knot in the middle

HD. After week (W) 96, participants transitioned to daily B/F/TAF to assess whether efficacy and safety would be maintained on this STR that is guidelines-recommended for PLWH with eGFR > 30 mL/min.


Methods. Virologically suppressed adult PLWH with ESRD on chronic HD who completed W96 on E/C/F/TAF enrolled in the B/F/TAF extension for 48 weeks. Efficacy was assessed as the proportion of participants with virologic suppression (HIV RNA < 50 copies/mL). Safety was assessed throughout the study, PK was assessed using sparse sampling at W4, 24 and 48.


Results. 55 enrolled, 36 completed E/C/F/TAF, 10 entered the B/F/TAF extension. The median age was 55 yrs (range 34-63); median time on HD was 4 yrs (range 2-16). All ten participants on B/F/TAF had HIV-1 RNA < 50 c/mL (95% CI 69%, 100%) at W48. All participants had at least 1 adverse event (AE); most were grade 1 or 2 in severity. One participant had a grade 3 AE and 3 had serious AEs; none were considered related to study drug by the investigator. One participant had AEs attributed to study drug (malaise grade 1 and nausea grade 2), which resolved and did not lead to discontinuation of study drug. There were no clinically relevant changes in fasting lipids. In participants with evaluable data (n=2-5 per timepoint), mean bictegravir trough concentrations were lower compared to PLWH not on HD but remained 4- to 7-fold higher than the established protein-adjusted 95% effective concentration (paEC95) of 162 ng/mL against wild-type virus.


Conclusion. A once daily regimen of B/F/TAF maintained virologic suppression in PLWH on chronic HD. B/F/TAF was well-tolerated with no discontinuations. B/F/ TAF may be an effective, safe and convenient once daily STR and ameliorate the need for dose adjustment in appropriate PLWH who require chronic HD.


Disclosures. Joseph J. Eron, MD, Gilead Sciences (Consultant, Research Grant or Support)Janssen (Consultant, Research Grant or Support)Merck (Consultant)ViiV Healthcare (Consultant, Research Grant or Support) Aimee Wilkin, MD, MPH, Gilead Sciences Inc. (Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member)GlaxoSmithKline (Grant/Research Support)Janssen (Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member)Pfizer (Grant/Research Support) Moti Ramgopal, MD FACP FIDSA, AbbVie (Speaker’s Bureau)Allergan (Speaker’s Bureau)Gilead Sciences Inc. (Consultant, Scientific Research Study Investigator, Speaker’s Bureau)Janssen (Speaker’s Bureau)Merck (Consultant)Viiv Healthcare (Consultant) Olayemi Osiyemi, M.D, GlaxoSmithKline (Advisor or Review Panel member, Speaker’s Bureau)ViiV Healthcare (Advisor or Review Panel member, Speaker’s Bureau) Jihad Slim, MD, Abbvie (Speaker’s Bureau)Gilead (Speaker’s Bureau)Jansen (Speaker’s Bureau)Merck (Speaker’s Bureau)ViiV (Speaker’s Bureau) David Asmuth, MD, Gilead Sciences Inc. (Scientific Research Study Investigator) Edwin DeJesus, MD, Gilead Sciences (Advisor or Review Panel member) Polina German, PharmD, Gilead Sciences (Employee) Christiana Blair, MS, Gilead Sciences (Employee, Shareholder) Christoph C. Carter, MD, Gilead Sciences Inc. (Employee, Shareholder) Diana M. Brainard, MD, Gilead Sciences (Employee) Sean E. Collins, MD, MS, Gilead Sciences (Employee) Hal Martin, MD, MPH, Gilead Sciences Inc. (Employee, Shareholder) 1003.


BIC/FTC/TAF Maintains Viral Suppression in Patients with Documented M184V/I Mutations: A Real World Experience Nicholas Chamberlain, MD1 ; James B. Brock, MD, MSCI, FACP1 ; Leandro A. Mena, MD, MPH1 ; 1 University of Mississippi Medical Center, Jackson, Mississippi


Session: P-47. HIV:

Treatment Background. The M184V/I mutation is a common mutation in treatment-experienced patients with HIV and confers high-level resistance to lamivudine and emtricitabine. Our objective is to assess the effectiveness of bictegravir (BIC)/emtricitabine (FTC)/tenofovir alafenamide (TAF) in a real-world setting in achieving and maintaining viral suppression in patients with documented M184V/I mutations.


Methods. This case series is comprised of treatment-experienced HIV-positive patients with documented historical or newly-identified M184V/I mutations who were placed on BIC/FTC/TAF as a switch strategy or as therapy for patients who had failed a prior regimen. Patients with any resistance to tenofovir or bictegravir were excluded. Our primary outcome was sustained viral suppression at 12 months after initiation of BIC/FTC/TAF.


Results. We included 33 patients (94% black, 52% male, median age 49, range 36-63) with an M184V/I mutation. The majority (91%) showed sustained viral suppression at 12 months of treatment. Non-adherence to medication was the common factor in all three cases of treatment failure. One patient developed an R263K mutation while on therapy, which conferred low-level resistance to bictegravir. There were no other instances of newly-acquired resistance to any of the components of BIC/FTC/TAF.


Conclusion. Our results demonstrate high success rates of BIC/FTC/ATF in achieving and maintaining viral suppression in patients with documented M184V/I mutations who adhere to medications in a real-world setting with a single instance of new treatment-emergent resistance to bictegravir. These findings are congruent with reported sub-group analysis in clinical trial data and support the use of BIC/FTC/TAF in patients with M184V/I mutations.


Disclosures. Leandro A. Mena, MD, MPH, Binx Health (Grant/Research Support)Evofem (Grant/Research Support)Gilead Science (Consultant, Grant/ Research Support, Speaker’s Bureau)GSK (Grant/Research Support)Janssen (Grant/ Research Support)Merck (Consultant, Grant/Research Support)Roche Molecular (Consultant, Grant/Research Support)SpeedDx (Grant/Research Support)ViiV Healthcare (Consultant, Grant/Research Support, Speaker’s Bureau)


1004. Clinical Decision Support System Alerts for HIV Retention in Care – A Pilot Implementation Research Study Michael Leonard, MD1 ; Rachel P. Weber, PhD2 ; Laurence Brunet, PhD2 ; Bernard Davis, PhDc, MBA3 ; Christopher Polk, MD1 ; Joel Wesley Thompson, MHS, PA-C, AAHIVS, DFAAPA, MHS, PA-C, AAHIVS, DFAAPA4 ; Jennifer S. Fusco, BS2 ; Tammeka Evans, MoP5 ; Pedro Eitz Ferrer, PhD, Master of Health Communication6 ; Rodney Mood, BS, MBA2 ; Gregory Fusco, MD, MPH2 ; 1 Atrium Health, Charlotte, North Carolina; 2 Epividian, Inc., Durham, North Carolina; 3 RAO Community Health, Charlotte, North Carolina; 4 Amity Medical Group, Charlotte, North Carolina; 5 ViiV Healthcare, Research Triangle Park, NC; 6 TBWA/WORLDHEALTH, New York, New York


Session: P-47.

HIV: Treatment Background. Clinical decision support system (CDSS) alerts may help retain people living with HIV (PLWH) in care. A system of CDSS alerts utilizing the CHORUS™ portal was developed to identify PLWH at risk of being lost to care. To evaluate feasibility for a larger scale study, a before and after implementation research pilot study was implemented in the OPERA Cohort at three clinic sites in a southeastern US city.


Methods. Periods without intervention (before) or with CDSS alerts (after) were followed by 3 months of follow up. The study population consisted of PLWH with ≥ 1 electronic health record entry in the 2 years prior to, or during, the before or after period (Fig 1). To support clinicians through a discrete implementation strategy, alerts warning of suboptimal patient attendance were generated daily for the eligible PLWH at each site; providers or other clinic staff could respond to the alerts (Fig 2). Alerts, responses, and visits (i.e., meeting with provider or HIV lab measurement) were characterized. The proportion of PLWH with ≥ 1 visit in the before and after periods were compared at each site by Pearson’s Chi-square.


Results. A total of 12,230 PLWH were eligible (sites A: 11,271; B: 733; C: 1,344 PLWH), with > 75% in both the before and after periods. The ratio of alerts to responses was 11.9 at site A (2,245 alerts to 189 responses in 309 days; Fig 3A), and comparatively lower at sites B (756 alerts to 334 responses in 352 days, ratio=2.2; Fig 3B) and C (1,305 alerts to 896 responses in 246 days, ratio=1.5; Fig 3C). Responses to alerts were sporadic at sites A and B and consistent at site C. After the intervention, the proportion of PLWH with ≥ 1 visit stayed the same at site A (46% in both periods; p=0.47), decreased at site B (91% to 80%; p< 0.01), and increased at site C (72% to 81%; p< 0.01).


Conclusion. This pilot study was ecological by design: measures of retention in care were compared over two calendar periods, without accounting for changes in study populations, clinic characteristics, and policies in place over time (which could have impacted clinic attendance). Though engagement with the CDSS was suboptimal at some sites, this implementation pilot study has demonstrated the ability to implement a CDSS aimed at identifying at-risk PLWH, while highlighting areas for improvement in future larger scale studies.


Disclosures. Joel Wesley Thompson, MHS, PA-C, AAHIVS, DFAAPA, MHS, PA-C, AAHIVS, DFAAPA, Gilead (Shareholder, Speaker’s Bureau)Janssen (Speaker’s Bureau)Theratechnologies (Speaker’s Bureau)ViiV (Speaker’s Bureau) Tammeka Evans, MoP, ViiV Healthcare (Employee)


1005. Comparison of Weight Changes in Treatment-Naïve, HIV-Infected Patients Receiving Integrase Inhibitor-Based Therapy Versus Protease Inhibitor-Based Therapy Zachary Howe, PharmD1 ; Eric Farmer, PharmD, BCPS, AAHIVP2 ; Brooke Stevens, PharmD, BCPS, AAHIVP2 ; Emily Huesgen, PharmD, BCACP, AAHIVP3 ; 1 Indiana University Health AHC, Indianapolis, Indiana; 2 Indiana University Health LifeCare Clinic, Indianapolis, Indiana; 3 Indiana University Health, Ellettsville, Indiana


Session: P-47. HIV:

Treatment Background. Recent data regarding integrase inhibitor (INSTI) therapy indicate possible association with weight gain. The incidence and degree of weight gain seems to vary by both patient-specific and regimen-related factors, such as nucleoside reverse transcriptase (NRTI) backbone.


Methods. This was a retrospective chart review of previously ART-naïve Indiana University Health LifeCare Clinic patients who started an INSTI- or PI-based regimens from 1/1/13 to 7/31/19. Adult patients without prior ART exposure receiving an INSTI- or PI-based regimen for at least 10 months were included. The primary objective was weight gain at 12 months after starting ART. Subgroup analyses were conducted by INSTI, PI, or NRTI backbone utilized. Statistical testing included Wilcoxon Rank-Sum Test and Chi Square analyses.


Results. The patient population (N=162) was predominately male and African American with relative immunocompetence, generally achieving viral suppression after 12 months of ART. Patients receiving PI-based therapy were more likely to be Asian American or Hispanic (p=0.04), and to receive a tenofovir disoproxil fumarate (TDF)-based regimen (p=0.0034). No statistically significant difference in weight change was observed between INSTI- and PI-based regimens (median weight gain 5.1 kg vs 3.9 kg, p=0.52). The proportion of obese or overweight patients in the INSTI arm increased significantly as compared to baseline (p=0.00001). Subgroup analyses demonstrated significant increases in weight gain and clinically significant weight gain with tenofovir-based (tenofovir alafenamide and TDF) regimens compared to those with abacavir/lamivudine (p< 0.05).

A blurred image of a pilot study timeline
A diagram of cdss alert criteria and response options
A few graphs on a white background with numbers on them
A graph showing a primary objective weight change

Authors: Michael Leonard, Rachel P Weber, Laurence Brunet, Bernard Davis, Christopher Polk, Joel Wesley Thompson, Jennifer S Fusco, Tammeka Evans, Pedro Eitz Ferrer, Rodney Mood, Gregory Fusco.

Read More From Amity Medical Group

September 22, 2026
Because you have a number of chronic conditions, looking after your health can become more difficult, as illnesses such as diabetes, heart disease, high blood pressure, arthritis, or chronic lung disease may require ongoing treatment, medications, changes to your way of life, and frequent visits to a medical professional. When someone has more than one health problem at the same time, chronic disease management and coordinated care can help to arrange their treatment and improve their overall health. If you work closely with your healthcare providers, you can make sure that your care plan takes into account your particular needs and health goals. Chronic disease management plays a significant role in the care offered at Amity Medical Group. The healthcare team works with patients to monitor ongoing conditions, support treatment plans, address changes in health, and help patients take an active role in their well-being. By providing continuous care and maintaining regular communication, we can monitor chronic conditions over time and adjust treatment when appropriate. What Are Chronic Conditions? Chronic conditions are health problems which tend to last for a long time and usually need continuous management. It is possible for some people to have more than one chronic condition, a state which is at times called having multiple chronic conditions. Common chronic conditions include: Diabetes High blood pressure Heart disease Arthritis Chronic obstructive pulmonary disease (COPD) Asthma Kidney disease When you have more than one condition, you may find that you need a number of medications, input from a variety of specialists, and different sets of treatment advice. It is essential that the different parts of your care stay connected. What Is Chronic Disease Management? Chronic disease management means continuously monitoring and treating long-term health conditions. Instead of focusing on a condition only when symptoms appear, chronic disease management emphasizes regular medical care, monitoring, prevention, and communication. Chronic disease management at Amity Medical Group can include looking over your medical history, keeping an eye on key health readings, assessing the medications you are taking, talking about your lifestyle habits, and tracking your progress over time. Your healthcare provider may also help spot changes that require further investigation or adjustments to your care plan. For people who have several disorders, managing their chronic diseases may be especially helpful since different health issues may influence each other. When a healthcare team has a good understanding of your full health situation, it will be able to offer a more thorough method of care. Why Coordinated Care Matters Should you have more than one chronic condition, each of them can have an effect on your overall health and might, in certain instances, affect how another condition is treated. With coordinated care, doctors and other healthcare professionals can communicate and work together when preparing your treatment plan and making changes to it. When taking more than one medication there is a greater chance of missing doses, experiencing side effects, or having drug interactions. It is helpful to have your medications regularly reviewed by your medical professional to ensure that they are still suitable for your requirements. The exchange of information between providers: When your primary care provider, specialists, pharmacists, and other members of your healthcare team share relevant health information, it will help them all to understand your present treatment plan. When planning your treatment, consider your health conditions, medications, lifestyle, preferences, and personal goals rather than addressing each condition in isolation. Ongoing monitoring involves regular appointments and health measurements so your doctor can track your condition over time and detect changes that may need attention. Preventive care such as regular screenings, checkups, vaccinations, and monitoring can help detect possible health problems early and support better long-term health. How Amity Medical Group Supports Chronic Disease Management Controlling a chronic condition usually takes more than one appointment or a single piece of advice; itis an ongoing process that can change as your health, medications, lifestyle,, or personal circumstances do. Amity Medical Group is specialists in the management of chronic diseases, offering continuous support to those who have long-term health conditions. We start by understanding each patient's specific health needs and creating a care plan that we can review and adjust as needed. By regularly visiting your healthcare team and staying in touch, chronic disease management can help you better understand your condition and the steps you can take to manage it. Your doctor can monitor your progress, discuss treatment options, review your medications, and address any concerns between visits. For people with several chronic conditions, this ongoing relationship is especially important; instead of treating each condition separately, your medical professional can consider how your health issues, medications, and lifestyle elements relate to one another. Tips for Managing Multiple Chronic Conditions To make managing chronic conditions easier, stay organized. The following are some useful habits: Maintain an up-to-date list of medications and dosages. Attend regular medical appointments and recommended screenings. Share changes in your health with your healthcare providers. Ask questions when you do not understand part of your treatment plan. Follow recommended guidelines regarding nutrition, physical activity, and lifestyle. Keep track of important health measurements when recommended, such as blood pressure or blood sugar. Make sure each provider knows about your other medical conditions and treatments. Discuss medication concerns or possible side effects with your healthcare provider. Work with your healthcare team to set realistic, manageable health goals. When to Speak with a Medical Provider If you develop new symptoms or your existing symptoms get worse, if you have any concerns regarding your medications, or if you find it difficult to stick to your treatment plan, you should discuss this with your healthcare provider. Do not stop or change your prescriptions without first talking to your healthcare provider. It is also important to keep to your scheduled appointments even if you are feeling well, since chronic disease management enables your healthcare provider to keep an eye on your ongoing conditions and to spot any changes that may require attention. If you have serious or sudden symptoms, get urgent or emergency medical help. Supporting Your Health Through Chronic Disease Management Looking after yourself when you have more than one chronic condition can be overwhelming, but it's not necessary for you to look after every aspect of your care by yourself. Amity Medical Group's chronic disease management service provides ongoing support to help patients better understand and manage their long-term health conditions. If you stay in touch with your healthcare team, monitor your medications and health information, attend regular appointments, and talk openly about any concerns you may have, you can play an active role in managing your health. Amity Medical Group focuses on managing chronic diseases and is dedicated to providing individualized, continuous care to patients with chronic health conditions. Discuss any health concerns, treatment goals, and questions with your medical provider so your care can be adjusted to meet your needs.
August 28, 2026
Dehydration happens when your body loses more fluids than it gets. Even if mild dehydration seems like a minor issue, not drinking enough can impact many parts of your body. Water helps control your temperature, keeps your blood moving, helps your kidneys remove waste, and supports normal body functions. Knowing the signs, causes, and effects of dehydration can help you stay hydrated and support your health. What Is Dehydration? Dehydration means your body doesn't have enough fluid to work properly. You lose water all the time through urination, sweating, breathing, and other daily activities. You may need more fluids if you exercise, are sick, are in hot weather, or take certain medicines. Increased thirst Dry mouth or lips Dark-colored urine Urinating less frequently Fatigue or weakness Headache Dizziness or lightheadedness Difficulty concentrating Severe dehydration could disrupt normal body functions and may require prompt medical care. How Dehydration Affects Your Body Water is important for almost every part of your body, so dehydration affects much more than just making you feel thirsty. Brain and mental function: Even mild dehydration may contribute to headaches, tiredness, difficulty concentrating, and changes regarding alertness. Heart and circulation: Having enough fluids helps keep your blood volume normal. If you get dehydrated, your blood pressure and heart rate can change, especially if you are older or have certain health problems. Kidneys and urinary system: Your kidneys need enough fluids to remove waste from your blood. Dehydration can make your urine darker and may raise the risk of kidney stones and other urinary problems. Muscles and joints: Fluids help your muscles work well. If you are dehydrated, you might get muscle cramps, feel weak, or not perform as well physically. Digestive health: Drinking enough water helps your digestion and can prevent constipation. Common Causes and Risk Factors Dehydration can happen for many reasons, including: Not drinking enough water throughout the day. Heavy sweating while engaging in physical activity Fever Vomiting or diarrhea Certain medications Spending extended periods in hot conditions Increased fluid needs during illness Older adults are at higher risk because they may not feel as thirsty as they age. People with some health conditions should also watch their fluid intake closely. Tips for Being Hydrated Maintaining hydration is simple if you build a few good habits, such as: Intaking fluids regularly throughout the day Keeping water nearby at home, work, or while traveling Drinking additional fluids while exercising Eating foods containing a lot of water, such as fruits and vegetables Paying attention to urine color as one general indicator of hydration Following a healthcare provider’s recommendations if you have fluid restrictions Water is a great choice for daily hydration, but how much you need depends on your age, activity, medicines, and health. When to Speak with a Medical Provider Talk to a medical provider if dehydration symptoms do not go away, get worse, or are hard to manage. Severe dehydration can cause confusion, fainting, very little urination, extreme weakness, or a fast heartbeat and may need urgent medical care. Protecting Your Health Through Proper Hydration It is easy to forget about dehydration, but drinking enough fluids is important for your health. Remaining hydrated helps your brain, heart, kidneys, muscles, digestion, and many other body functions.  If you drink fluids regularly, watch for early signs of dehydration, and talk to your medical professional about any concerns, you can make hydration part of your daily routine. Amity Medical Group encourages you to take charge of your health and discuss your hydration needs during regular checkups.
July 31, 2026
Metabolic syndrome is a plethora of health conditions that happen together, increasing the chances of heart disease, stroke, type 2 diabetes, and chronic conditions. Because it often develops gradually without symptoms, many people may be unaware they are at risk. Early recognition and healthy lifestyle changes can prevent serious complications and support sustained health. Understanding metabolic syndrome and its associated risk factors helps individuals to take informed decisions that protect their overall health. What Is Metabolic Syndrome? Metabolic syndrome is not one disease but a combination of several that occur simultaneously. A healthcare provider may diagnose metabolic syndrome when a person has three or more of the following: Elevated blood pressure High blood sugar levels Excess body fat around the waist High triglyceride levels Low levels of HDL (“good”) cholesterol Each of these conditions places additional strain on the body’s cardiovascular and metabolic systems. Together, they greatly increase the risk of serious health complications. Higher blood sugar can damage blood vessels over time, while high blood pressure places extra stress on the heart and arteries. Abnormal cholesterol and triglyceride levels may contribute to plaque buildup in the blood vessels, reducing healthy circulation. Without proper management, metabolic syndrome may increase the risk of: Heart disease Stroke Type 2 diabetes Kidney disease Fatty liver disease Many of these risks can be reduced through early detection and consistent lifestyle changes. Common Risk Factors Certain variables may increase the likelihood of developing metabolic syndrome, including: Excess body weight, especially around the abdomen Physical inactivity Diets high in processed foods, added sugars, and rich in saturated fats Increasing age Family history of diabetes or heart disease Smoking or tobacco use Poor sleep habits Ongoing stress Some risk factors cannot be changed, but many can be adjusted through healthy habits and regular medical care. Supporting Metabolic Health Every Day Healthy lifestyle actions play a key role in preventing and managing metabolic syndrome. Small, consistent changes can improve health and reduce future risk. Helpful habits include: Eating a well-rounded diet with food groups like vegetables, fruits, whole grains, low-fat proteins, and healthy fats Limiting sugary beverages, processed foods, and excess sodium Participating in rregularly scheduled physical activity, such as walking, cycling, or strength training Maintaining a healthy weight Getting consistent, sound rest each night Avoiding tobacco products Scheduling routine wellness visits and recommended health screenings Healthcare providers may recommend medications to manage blood pressure, cholesterol, or blood sugar when lifestyle changes are insufficient. When to Speak with a Medical Provider Metabolic syndrome often develops without symptoms, so routine health screenings are essential. Speak with a medical provider if you experience or have concerns about: Elevated blood pressure readings High blood sugar or prediabetes Increasing waist circumference Abnormal cholesterol or triglyceride levels Unexplained fatigue A family history of heart disease or diabetes Regular checkups let healthcare providers monitor health indicators and recommend preventive care before complications arise. Protecting Your Long-Term Health Metabolic syndrome is called a “silent” health risk because it can progress unnoticed for years. It is also one of the most controllable chronic concerns when identified early. Healthy nutrition, regular physical exercise, routine medical care, and attention to key health measurements can greatly lower the risk of serious complications. Taking a proactive approach to metabolic health today can support healthier aging, enhance overall well-being, and minimize the chances of chronic disease in the years ahead. 
Show More